Cargando…
Neurotoxicity Associated With Cancer Therapy
Neurologic complications can result from direct or indirect effects of cancer therapy. Treatment toxicity may affect both the central nervous system and the peripheral nervous system. Early recognition of these toxicities plays an important role in the management of patients with cancer.
Autores principales: | Lu Lee, Eva, Westcarth, Laurel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093294/ https://www.ncbi.nlm.nih.gov/pubmed/25031923 |
Ejemplares similares
-
EDTA Chelation Therapy for the Treatment of Neurotoxicity
por: Fulgenzi, Alessandro, et al.
Publicado: (2019) -
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
por: Morris, Emma C., et al.
Publicado: (2021) -
Recent Topics on The Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities
por: Zhang, Wei, et al.
Publicado: (2019) -
Nanoparticles and Neurotoxicity
por: Win-Shwe, Tin-Tin, et al.
Publicado: (2011) -
Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy
por: Velasco, Roser, et al.
Publicado: (2021)